In less than a year, a new injectable that diminishes that pesky double chin will be on the market. According to the New York Daily News, Kythera Biopharmaceuticals Inc. confirmed on Monday that an advisory panel for the Food and Drug Administration has approved ATX-101, an injectable that ruptures fat cells in the chin, using deoxycholic acid. Deoxycholic acid is found naturally in the intestines, where it breaks down fat during digestion.
Double chins — i.e. when skin hangs from your neck thanks to gravity— can occur regardless of age or weight. This drug would work to specifically target this small area by having the body absorb and excrete the ruptured excess fat cells.
The FDA approved this fat melting compound solely for the face’s submental compartment, which is the area just below the chin, in the “turkey neck” region. So, this isn’t something someone will be able to have injected into their thighs or abs hoping for the same fat busting results (maybe one day folks), but for now, this is still a huge step for cosmetic procedures.
This fat buster is a fantastic nonsurgical option for those unwilling to do a more invasive procedure. The treatment involves a series of injections administered one month a part. The clinical trials included an administration of the drug to more than 2,600 patients in two dozen studies over eight years. Although, some people have reported bruising, numbness and swelling, and more serious side effects like trouble swallowing, these side effects didn’t last long, Today reports.
This is good news for all of us who love taking a good old-fashion selfie. All your solo shots taken with your double, triple and even quadruple chin showing might be on their way out for good!